Brief: Amplitude Surgical FY Net Loss Narrows To EUR 4.4 Mln

Amplitude Surgical SA

19/10/2022 17:42

Oct 19 (Reuters) - AMPLITUDE SURGICAL SA  AMPLI.PA :
    * AMPLITUDE SURGICAL – 2021-22 ANNUAL RESULTS: SALES OF
€87.6M AND
EBITDA OF €22.0M
    * INCREASE IN FY EBITDA TO €22.0 MILLION (+10.9%) WITH AN
EBITDA
MARGIN OF 25.1%
    * CASH POSITION OF €21.0 MILLION AT END-JUNE 2022
    * FY NET RESULT (GROUP SHARE) WAS A LOSS OF €4.4 MILLION,
VERSUS A
NET LOSS OF €14.1M THE PREVIOUS YEAR
    * TO ADDRESS THE PROCUREMENT RISK, THE GROUP IS CONDUCTING
THOROUGH COMMERCIAL FORECAST REVIEWS AND ADOPTING PURCHASING
COMMITMENTS OVER LONGER TIMEFRAMES
    * GROUP HAS NO COMMERCIAL EXPOSURE IN UKRAINE OR RUSSIA
    * IS ANTICIPATING: A RETURN TO THE PRE-COVID GROWTH
TRAJECTORY
AFTER AN INITIAL UPTURN IN 2021-22, RESULTING IN ANNUAL SALES OF
APPROXIMATELY €129 MILLION IN 2022-23 (INCLUDING FOOT AND ANKLE
ACTIVITY – EXCLUDING IFRS 5)
    * IS ANTICIPATING: AN EBITDA MARGIN OF AROUND 21% IN 2022-23
(INCLUDING FOOT AND ANKLE ACTIVITY – EXCLUDING IFRS 5)

Source text for Eikon:  ID:nBw5wX8Dta 
Further company coverage:  AMPLI.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))